US States Sue Trump Admin Over Vaccine Policy
Analysis based on 8 articles · First reported Feb 24, 2026 · Last updated Feb 25, 2026
The lawsuit against the Trump administration's vaccine policy could create uncertainty for pharmaceutical companies involved in vaccine production, potentially affecting their stock performance. A resurgence of preventable diseases due to lower vaccination rates could also strain healthcare systems and impact public health spending.
Fifteen Democratic-run US states, led by United States===California and United States===Arizona, are suing President Donald Trump's administration over its decision to reduce the number of universally recommended pediatric vaccines. The reform, announced in January by the United States===United States Department of Health and Human Services under Robert F. Kennedy Jr., shifts seven vaccines, including those for influenza, hepatitis A and B, and Covid-19, from universal recommendation to only for children at particular risk. Plaintiffs, including United States===California Attorney General Rob Bonta and United States===Arizona Attorney General Kris Mayes, criticize the move as unscientific and a threat to public health, arguing it flouts decades of research and endangers children. Robert F. Kennedy Jr., the United States===Centers for Disease Control and Prevention, and the United States===United States Department of Health and Human Services are named as defendants. The Trump administration justified the change by aligning US policy with other countries, citing Denmark, a comparison criticized by health experts due to differences in healthcare systems. United States===California Governor Gavin Newsom also condemned the policy, warning of lower vaccination rates and increased infectious diseases.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard